Myomo (NYSE:MYO) PT Raised to $8.00

Myomo (NYSE:MYO) had its target price boosted by investment analysts at Colliers Secur. from $7.00 to $8.00 in a research note issued to investors on Wednesday, The Fly reports. Colliers Secur.’s price target indicates a potential upside of 60.32% from the company’s current price.

Shares of NYSE:MYO traded down $0.36 on Wednesday, hitting $4.99. The company had a trading volume of 918,679 shares, compared to its average volume of 191,503. The stock has a market cap of $18.31 million, a PE ratio of -0.38 and a beta of 1.21.

About Myomo

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace orthosis product used for supporting a patient's weak or paralyzed arm to enable and enhance functional activities of daily living, ADLs, in the home and community.

Recommended Story: Learning About the VIX – Volatility Index

The Fly

Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit